ALIFE results Adamjee Life Assurance Company Limited
Adamjee Life Assurance Company Limited (ALIFE) has 9 results with figures on file. Quarter ended 30 Sep 2026: earnings per share Rs 0.47, down 69.1% on the same quarter a year before. The next results are expected between 17 Feb 2027 and 7 Mar 2027 (a projection, not an announced date).
One line for each result
- Quarter ended 30 Sep 2026: earnings per share Rs 0.47, down 69.1% on the same quarter a year before.
- Quarter ended 30 Jun 2026: earnings per share Rs 1.28, down 26.4% on the same quarter a year before.
- Quarter ended 31 Mar 2026: earnings per share Rs 0.35.
- Year ended 31 Dec 2025: earnings per share Rs 5.01, down 15.4% on the year before.
- Quarter ended 30 Sep 2025: earnings per share Rs 1.52.
- Quarter ended 30 Jun 2025: earnings per share Rs 1.74.
- Year ended 31 Dec 2024: earnings per share Rs 5.92, up 71.2% on the year before.
- Year ended 31 Dec 2023: earnings per share Rs 3.46, up 82.4% on the year before.
- Year ended 31 Dec 2022: earnings per share Rs 1.90.
Written from the figures below. Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later.
When the next results are due
Next results
Full-year results, to 31 Dec 2026: expected between 17 Feb 2027 and 7 Mar 2027.
A projection, not an announced date. An estimate from the dates of the last 3 filings.
Results dates on record
| Date | What | Status |
|---|---|---|
| 17 Feb 2027 | Full-year results expected between 17 Feb 2027 and 7 Mar 2027 | Expected window, not an announced date |
| 26 Oct 2026 | Nine-month results, to 30 Sep 2026 | Filed with the exchange |
Source: the exchange’s results announcements. An expected window is an estimate from the dates of earlier filings.
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 0.47 | — | Rs 122.1 m | — | -69.1% |
| Quarter to 30 Jun 2026 | 1.28 | — | Rs 335.9 m | — | -26.4% |
| Quarter to 31 Mar 2026 | 0.35 | — | Rs 91.3 m | — | — |
| Quarter to 30 Sep 2025 | 1.52 | — | Rs 398.4 m | — | — |
| Quarter to 30 Jun 2025 | 1.74 | — | Rs 457.1 m | — | — |
Results filings at the exchange
| Date | Filing | Kind | |
|---|---|---|---|
| 30 Oct 2026 | Transmission of Quarterly Report for the Period Ended September 30, 2026 | Quarterly accounts | |
| 26 Oct 2026 | Financial Results for the Quarter Ended September 30, 2026 | Quarterly accounts | |
| 28 Aug 2026 | Quarterly report 2026 | Quarterly accounts | |
| 25 Aug 2026 | Financial Results for the Quarter Ended June 30, 2026 | Quarterly accounts | |
| 27 Apr 2026 | Financial Results for the Quarter Ended March 31, 2026 | Quarterly accounts | |
| 31 Mar 2026 | Quarterly report 2026 | Quarterly accounts | |
| 30 Sep 2025 | Quarterly report 2025 | Quarterly accounts | |
| 30 Jun 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Mar 2025 | Quarterly report 2025 | Quarterly accounts | |
| 30 Sep 2024 | Quarterly report 2024 | Quarterly accounts | |
| 30 Jun 2024 | Quarterly report 2024 | Quarterly accounts | |
| 31 Mar 2024 | Quarterly report 2024 | Quarterly accounts | |
| 30 Sep 2023 | Quarterly report 2023 | Quarterly accounts | |
| 30 Jun 2023 | Quarterly report 2023 | Quarterly accounts | |
| 31 Mar 2023 | Quarterly report 2023 | Quarterly accounts | |
| 30 Sep 2022 | Quarterly report 2022 | Quarterly accounts | |
| 30 Jun 2022 | Quarterly report 2022 | Quarterly accounts | |
| 31 Mar 2022 | Quarterly report 2022 | Quarterly accounts |
18 filings stored.
More on ALIFE
- ALIFE share price and overview
- ALIFE dividend history
- Insurance sector
- ASIC results · Asia Insurance Company Limited
- ATIL results · Atlas Insurance Limited
- IGIHL results · IGI Holdings Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .